How long does it take to get an IRB study approved?

Institutional Review Boards (IRBs) can be classified into two groups; private and hospital/clinic based groups. The private institutions typically review cases in a short period of time, based on client requests to determine the safety concerns to classify studies as low/medium or high risk. 

A low risk study means that the surgeon or physician has alternatives and mitigation options to the studied device and can override any unsafe conditions to prevent adverse events. High risk studies have the potential to harm a patient, and will require extensive testing and risk mitigations to potentially be approved for a study. These cases may potentially never be approved depending on the center rules and guidelines and may require controlled clinical study protocols to proceed instead, which is referred to as Investigational New Device (IND) or Investigational Device Exemption (IDE) filings with the FDA. This process can take 1 to 2 years to clear depending on the complexity of the device and competence of the design and regulatory teams.

Given those designations, for private IRBs,  low risk studies can be reviewed and approved in a matter of weeks, and high risk items can take much longer periods, in the form of quarters based on needs for enrollment, safety, etc. 

Conversely, hospital based IRBs can take a longer period of time due to the structure of the group. Typical hospital IRB only meets monthly to discuss the items on deck. This means that depending on the scheduling, the study can wait for up to 2 months before a full review. 

Typically, there are many questions that are asked from the initiator which will then be reviewed again in the next meeting. A low risk study will take at least 3 months to review before approval, and a high risk study may never be approved due to the perceived risk to the hospital and the patients.

Have specific questions about your IRB? Schedule some time to chat with an expert using the link in the box below.

Explore solutions with a Nemedio expert
Schedule a Call

What’s a Rich Text element?

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

What’s a Rich Text element?

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

Test caption

What’s a Rich Text element?

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

What’s a Rich Text element?

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

  • sgsgdsg
  • sgdsgsgdsg
  1. sgsgdsg
  2. sgdsgsgdsg
What’s a Rich Text element?
The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Vivamus suscipit tortor eget felis porttitor volutpat. Pellentesque in ipsum id orci porta dapibus

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

1.

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

The Nemedio Blog:  Demystifying Compliance

your guide to product development and compliance for medical technology
FAQ

How long does it take to get an IRB study approved?

April 14, 2022

Institutional Review Boards (IRBs) can be classified into two groups; private and hospital/clinic based groups. The private institutions typically review cases in a short period of time, based on client requests to determine the safety concerns to classify studies as low/medium or high risk. 

A low risk study means that the surgeon or physician has alternatives and mitigation options to the studied device and can override any unsafe conditions to prevent adverse events. High risk studies have the potential to harm a patient, and will require extensive testing and risk mitigations to potentially be approved for a study. These cases may potentially never be approved depending on the center rules and guidelines and may require controlled clinical study protocols to proceed instead, which is referred to as Investigational New Device (IND) or Investigational Device Exemption (IDE) filings with the FDA. This process can take 1 to 2 years to clear depending on the complexity of the device and competence of the design and regulatory teams.

Given those designations, for private IRBs,  low risk studies can be reviewed and approved in a matter of weeks, and high risk items can take much longer periods, in the form of quarters based on needs for enrollment, safety, etc. 

Conversely, hospital based IRBs can take a longer period of time due to the structure of the group. Typical hospital IRB only meets monthly to discuss the items on deck. This means that depending on the scheduling, the study can wait for up to 2 months before a full review. 

Typically, there are many questions that are asked from the initiator which will then be reviewed again in the next meeting. A low risk study will take at least 3 months to review before approval, and a high risk study may never be approved due to the perceived risk to the hospital and the patients.

Have specific questions about your IRB? Schedule some time to chat with an expert using the link in the box below.

RELATED

Chat with an Expert

Stuck on a particular problem? Speak with an expert to get your questions answered.